Bristol-Myers Squibb CoNYSE:BMY
- LAST PRICE59.2100
- TODAY'S CHANGE (%)-0.0600 (-0.1012%)
- Bid / Lots59.2000/ 7
- Ask / Lots59.2100/ 7
- Open / Previous Close59.3300 / 59.2700
- Day Range
- 52 Week Range
- Volume2,532,045
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BMY |
|---|---|---|
| 09:32 ET | 212809 | 59.34 |
| 09:33 ET | 29712 | 59.43 |
| 09:35 ET | 23350 | 59.16 |
| 09:37 ET | 15185 | 59.225 |
| 09:39 ET | 12907 | 59.235 |
| 09:42 ET | 11276 | 59.18 |
| 09:44 ET | 43911 | 59.13 |
| 09:46 ET | 14831 | 59.1024 |
| 09:48 ET | 26032 | 59.15 |
| 09:50 ET | 8501 | 59.1725 |
| 09:51 ET | 13146 | 59.15 |
| 09:53 ET | 7979 | 59.14 |
| 09:55 ET | 9498 | 59.2 |
| 09:57 ET | 12309 | 59.19 |
| 10:00 ET | 13544 | 59.15 |
| 10:02 ET | 25840 | 59.2 |
| 10:04 ET | 24679 | 59.27 |
| 10:06 ET | 32368 | 59.31 |
| 10:08 ET | 10484 | 59.345 |
| 10:09 ET | 14308 | 59.175 |
| 10:11 ET | 14506 | 59.2211 |
| 10:13 ET | 8993 | 59.19 |
| 10:15 ET | 11351 | 59.175 |
| 10:18 ET | 13049 | 59.175 |
| 10:20 ET | 15761 | 59.19 |
| 10:22 ET | 6776 | 59.15 |
| 10:24 ET | 15637 | 59.13 |
| 10:26 ET | 7740 | 59.14 |
| 10:27 ET | 10440 | 59.185 |
| 10:29 ET | 36298 | 59.215 |
| 10:31 ET | 10364 | 59.185 |
| 10:33 ET | 13867 | 59.14 |
| 10:36 ET | 18974 | 59.015 |
| 10:38 ET | 17922 | 59.03 |
| 10:40 ET | 12626 | 59.01 |
| 10:42 ET | 8415 | 59.08 |
| 10:44 ET | 61082 | 59.045 |
| 10:45 ET | 14629 | 59.005 |
| 10:47 ET | 14590 | 59.03 |
| 10:49 ET | 15925 | 59.045 |
| 10:51 ET | 34394 | 59.13 |
| 10:54 ET | 8577 | 59.1927 |
| 10:56 ET | 17651 | 59.14 |
| 10:58 ET | 21151 | 59.12 |
| 11:00 ET | 8387 | 59.14 |
| 11:02 ET | 16047 | 59.165 |
| 11:03 ET | 11891 | 59.145 |
| 11:05 ET | 11702 | 59.125 |
| 11:07 ET | 12529 | 59.17 |
| 11:09 ET | 59846 | 59.27 |
| 11:12 ET | 61224 | 59.26 |
| 11:14 ET | 20337 | 59.16 |
| 11:16 ET | 24380 | 59.18 |
| 11:18 ET | 15617 | 59.105 |
| 11:20 ET | 11118 | 59.115 |
| 11:21 ET | 12148 | 59.095 |
| 11:23 ET | 41155 | 59.01 |
| 11:25 ET | 12039 | 59.065 |
| 11:27 ET | 28698 | 59.03 |
| 11:30 ET | 13542 | 59.035 |
| 11:32 ET | 15303 | 59.03 |
| 11:34 ET | 11540 | 59.04 |
| 11:36 ET | 8144 | 59.085 |
| 11:38 ET | 18882 | 59.06 |
| 11:39 ET | 10558 | 59.055 |
| 11:41 ET | 8109 | 59.075 |
| 11:43 ET | 9887 | 59.085 |
| 11:45 ET | 9271 | 59.095 |
| 11:48 ET | 11336 | 59.11 |
| 11:50 ET | 8348 | 59.115 |
| 11:52 ET | 11819 | 59.125 |
| 11:54 ET | 10565 | 59.14 |
| 11:56 ET | 11727 | 59.14 |
| 11:57 ET | 8759 | 59.14 |
| 11:59 ET | 13529 | 59.135 |
| 12:01 ET | 11024 | 59.135 |
| 12:03 ET | 11446 | 59.14 |
| 12:06 ET | 9056 | 59.165 |
| 12:08 ET | 10236 | 59.21 |
| 12:10 ET | 8309 | 59.22 |
| 12:12 ET | 15533 | 59.25 |
| 12:14 ET | 14172 | 59.23 |
| 12:15 ET | 13230 | 59.26 |
| 12:17 ET | 11269 | 59.27 |
| 12:19 ET | 14782 | 59.265 |
| 12:21 ET | 14670 | 59.22 |
| 12:24 ET | 10739 | 59.245 |
| 12:26 ET | 7692 | 59.24 |
| 12:28 ET | 13738 | 59.255 |
| 12:30 ET | 9960 | 59.26 |
| 12:32 ET | 10594 | 59.285 |
| 12:33 ET | 23053 | 59.32 |
| 12:35 ET | 12055 | 59.3502 |
| 12:37 ET | 19016 | 59.305 |
| 12:39 ET | 16488 | 59.315 |
| 12:42 ET | 16086 | 59.325 |
| 12:44 ET | 15829 | 59.3 |
| 12:46 ET | 20175 | 59.295 |
| 12:48 ET | 23700 | 59.305 |
| 12:50 ET | 35827 | 59.3 |
| 12:51 ET | 30537 | 59.225 |
| 12:53 ET | 48222 | 59.185 |
| 12:55 ET | 34461 | 59.21 |
Nov 26, 2024
Bristol Myers Squibb to Participate in Citi's 2024 Global Healthcare Conference, from 6:59AM ET on Tuesday Nov 26, 2024 by Dow Jones
6:59AM ET on Tuesday Nov 26, 2024 by Dow Jones
Nov 22, 2024
DJ Pension Doubles Its Palantir Stake and Buys Up Intel and CVS. -- Barron's, from 9:30PM ET on Friday Nov 22, 2024 by Dow Jones
9:30PM ET on Friday Nov 22, 2024 by Dow Jones
Nov 19, 2024
Nov 17, 2024
DJ Large Pension Doubled Palantir Stake, Bought Up Intel and CVS Stock -- Barrons.com, from 3:00AM ET on Sunday Nov 17, 2024 by Dow Jones
3:00AM ET on Sunday Nov 17, 2024 by Dow Jones
Nov 15, 2024
Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo(R) (nivolumab) plus Yervoy(R) (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite Instability--High or Mismatch Repair Deficient Metastatic Colorectal Cancer, from 8:23AM ET on Friday Nov 15, 2024 by Dow Jones
8:23AM ET on Friday Nov 15, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Bristol-Myers Squibb Co | 120.2B | -16.5x | +4.90% |
Sanofi SA | 123.3B | 25.6x | +4.55% |
GSK plc | 70.5B | 22.1x | +6.39% |
AstraZeneca PLC | 208.4B | 32.5x | +17.52% |
Pfizer Inc | 146.4B | 35.2x | -7.10% |
Gilead Sciences Inc | 113.8B | 1,103.0x | +1.53% |
Company Information
Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor (CAR-T) cell therapies. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are used as well. Biologics are administered to patients through injections or by intravenous infusion. Its in-line products include Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Yervoy, Sprycel, Reblozyl, Opdualag, Abecma, Zeposia, and others. The Company's product pipeline includes Krazati, MRTX1719, RYZ101, KarXT, ORM-6151, and Repotrectinib.
Contact Information
- Headquarters
- Route 206 And Province Line RoadPRINCETON, NJ, United States 08543
- Phone
- 609-252-4621
- Fax
- 302-655-5049
Executives
- Chairman of the Board, Chief Executive Officer, Chief Operating Officer
- Christopher Boerner
- Executive Vice President, Chief Financial Officer, Member of the Leadership Team
- David Elkins
- President, Cell Therapy Organization, Member of the Leadership Team
- Lynelle Hoch
- Chief Human Resource Officer, Executive Vice President, Member of the Leadership Team
- Amanda Poole
- Executive Vice President, Chief Digital and Technology Officer, Member of the Leadership Team
- Greg Meyers
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $120.2B |
|---|---|
Revenue (TTM) | $47.4B |
Shares Outstanding | 2.0B |
Dividend Yield | 4.05% |
Annual Dividend Rate | 2.4000 USD |
Ex-Dividend Date | 10-04-24 |
Pay Date | 11-01-24 |
Beta | 0.45 |
EPS | $-3.60 |
Book Value | $14.56 |
P/E Ratio | -16.5x |
Price/Sales (TTM) | 2.5 |
Price/Cash Flow (TTM) | 40.9x |
Operating Margin | -12.02% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
